nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP3A4—Temozolomide—malignant glioma	0.256	1	CbGbCtD
Mebendazole—TUBA1A—pons—malignant glioma	0.0627	0.211	CbGeAlD
Mebendazole—TUBA1A—pineal body—malignant glioma	0.0447	0.151	CbGeAlD
Mebendazole—TUBA1A—embryo—malignant glioma	0.0152	0.0514	CbGeAlD
Mebendazole—TUBA1A—brainstem—malignant glioma	0.014	0.0471	CbGeAlD
Mebendazole—TUBA1A—retina—malignant glioma	0.0135	0.0454	CbGeAlD
Mebendazole—TUBA1A—telencephalon—malignant glioma	0.0124	0.0418	CbGeAlD
Mebendazole—TUBB4B—embryo—malignant glioma	0.0101	0.0342	CbGeAlD
Mebendazole—TUBA1A—medulla oblongata—malignant glioma	0.00973	0.0328	CbGeAlD
Mebendazole—TUBB4B—retina—malignant glioma	0.00897	0.0303	CbGeAlD
Mebendazole—TUBA1A—midbrain—malignant glioma	0.00889	0.03	CbGeAlD
Mebendazole—TUBA1A—spinal cord—malignant glioma	0.00868	0.0293	CbGeAlD
Mebendazole—TUBB4B—telencephalon—malignant glioma	0.00825	0.0278	CbGeAlD
Mebendazole—TUBA1A—central nervous system—malignant glioma	0.00704	0.0237	CbGeAlD
Mebendazole—TUBA1A—cerebellum—malignant glioma	0.00688	0.0232	CbGeAlD
Mebendazole—TUBB4B—medulla oblongata—malignant glioma	0.00649	0.0219	CbGeAlD
Mebendazole—TUBB4B—midbrain—malignant glioma	0.00593	0.02	CbGeAlD
Mebendazole—TUBB4B—spinal cord—malignant glioma	0.00578	0.0195	CbGeAlD
Mebendazole—TUBA1A—brain—malignant glioma	0.00559	0.0189	CbGeAlD
Mebendazole—Ketorolac—PTGS1—malignant glioma	0.00524	0.193	CrCbGaD
Mebendazole—ABCB1—blood vessel—malignant glioma	0.00495	0.0167	CbGeAlD
Mebendazole—TUBB4B—central nervous system—malignant glioma	0.00469	0.0158	CbGeAlD
Mebendazole—TUBB4B—cerebellum—malignant glioma	0.00459	0.0155	CbGeAlD
Mebendazole—Tiaprofenic acid—PTGS1—malignant glioma	0.00427	0.157	CrCbGaD
Mebendazole—Nepafenac—PTGS1—malignant glioma	0.00406	0.15	CrCbGaD
Mebendazole—TUBB4B—brain—malignant glioma	0.00372	0.0126	CbGeAlD
Mebendazole—Ketoprofen—CXCL8—malignant glioma	0.00322	0.119	CrCbGaD
Mebendazole—Ketorolac—PTGS2—malignant glioma	0.00299	0.11	CrCbGaD
Mebendazole—ABCB1—embryo—malignant glioma	0.00295	0.00996	CbGeAlD
Mebendazole—CYP1A1—central nervous system—malignant glioma	0.00263	0.00886	CbGeAlD
Mebendazole—ABCB1—retina—malignant glioma	0.00261	0.0088	CbGeAlD
Mebendazole—Tiaprofenic acid—PTGS2—malignant glioma	0.00244	0.0899	CrCbGaD
Mebendazole—ABCB1—telencephalon—malignant glioma	0.0024	0.0081	CbGeAlD
Mebendazole—Nepafenac—PTGS2—malignant glioma	0.00232	0.0855	CrCbGaD
Mebendazole—CYP1A1—brain—malignant glioma	0.00209	0.00704	CbGeAlD
Mebendazole—CYP3A4—central nervous system—malignant glioma	0.00193	0.0065	CbGeAlD
Mebendazole—ABCB1—medulla oblongata—malignant glioma	0.00189	0.00636	CbGeAlD
Mebendazole—ABCB1—midbrain—malignant glioma	0.00172	0.00582	CbGeAlD
Mebendazole—ABCB1—spinal cord—malignant glioma	0.00168	0.00567	CbGeAlD
Mebendazole—Ketoprofen—PTGS1—malignant glioma	0.00165	0.0607	CrCbGaD
Mebendazole—ABCB1—central nervous system—malignant glioma	0.00136	0.0046	CbGeAlD
Mebendazole—ABCB1—cerebellum—malignant glioma	0.00133	0.0045	CbGeAlD
Mebendazole—ABCB1—brain—malignant glioma	0.00108	0.00365	CbGeAlD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00104	0.00248	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—APOD—malignant glioma	0.00104	0.00247	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.00103	0.00246	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.00103	0.00244	CbGpPWpGaD
Mebendazole—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.00102	0.00244	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000965	0.00229	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TOP2A—malignant glioma	0.000961	0.00228	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000953	0.00227	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000952	0.00226	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—H3F3A—malignant glioma	0.000952	0.00226	CbGpPWpGaD
Mebendazole—Ketoprofen—PTGS2—malignant glioma	0.000941	0.0347	CrCbGaD
Mebendazole—TUBA1A—Cell Cycle—YWHAE—malignant glioma	0.000917	0.00218	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000903	0.00215	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—XBP1—malignant glioma	0.000879	0.00209	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP2B6—malignant glioma	0.000844	0.00201	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PLK1—malignant glioma	0.00084	0.002	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000836	0.00199	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000833	0.00198	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000832	0.00198	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000825	0.00196	CbGpPWpGaD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000789	0.00188	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000788	0.00187	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000782	0.00186	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.00077	0.00183	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000768	0.00182	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PLK1—malignant glioma	0.000751	0.00178	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—BCHE—malignant glioma	0.000745	0.00177	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—HIST1H3B—malignant glioma	0.000744	0.00177	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—FBXW7—malignant glioma	0.000733	0.00174	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—CYP2C18—malignant glioma	0.000732	0.00174	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000722	0.00172	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000696	0.00165	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—BRCA2—malignant glioma	0.000695	0.00165	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2B—malignant glioma	0.000689	0.00164	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000678	0.00161	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000665	0.00158	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—SPHK1—malignant glioma	0.000652	0.00155	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000649	0.00154	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000643	0.00153	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000637	0.00151	CbGpPWpGaD
Mebendazole—CYP1A1—Tryptophan metabolism—MDM2—malignant glioma	0.000633	0.00151	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000631	0.0015	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000619	0.00147	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000611	0.00145	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—BIRC5—malignant glioma	0.000594	0.00141	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTT1—malignant glioma	0.000592	0.00141	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TOP2A—malignant glioma	0.00058	0.00138	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TERT—malignant glioma	0.000576	0.00137	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—H3F3A—malignant glioma	0.000575	0.00137	CbGpPWpGaD
Mebendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000571	0.00136	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000571	0.00136	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000568	0.00135	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000566	0.00135	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000564	0.00134	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—PTGS1—malignant glioma	0.000555	0.00132	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—YWHAE—malignant glioma	0.000554	0.00132	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000546	0.0013	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—NCOR1—malignant glioma	0.000539	0.00128	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000537	0.00128	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000534	0.00127	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000532	0.00127	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.000528	0.00125	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000527	0.00125	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000514	0.00122	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.0005	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000495	0.00118	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000489	0.00116	CbGpPWpGaD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000486	0.00116	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000481	0.00114	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000465	0.00111	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000465	0.00111	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—BCHE—malignant glioma	0.00045	0.00107	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000445	0.00106	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000442	0.00105	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—FBXW7—malignant glioma	0.000442	0.00105	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000441	0.00105	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000433	0.00103	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000433	0.00103	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—F2—malignant glioma	0.000423	0.001	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—BRCA2—malignant glioma	0.00042	0.000997	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000417	0.000992	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2B—malignant glioma	0.000416	0.000989	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000415	0.000987	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RTEL1—malignant glioma	0.000415	0.000986	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000412	0.00098	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000412	0.00098	CbGpPWpGaD
Mebendazole—CYP1A1—Biological oxidations—GSTP1—malignant glioma	0.00041	0.000975	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.00041	0.000974	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000409	0.000972	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000407	0.000968	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000406	0.000966	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—GSTP1—malignant glioma	0.000405	0.000962	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000401	0.000954	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—malignant glioma	0.000394	0.000936	CbGpPWpGaD
Mebendazole—CYP1A1—PPARA activates gene expression—PPARG—malignant glioma	0.000386	0.000918	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MDM2—malignant glioma	0.000382	0.000908	CbGpPWpGaD
Mebendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000378	0.000899	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000372	0.000883	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000364	0.000864	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.00036	0.000856	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—BIRC5—malignant glioma	0.000359	0.000853	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—MMP2—malignant glioma	0.000358	0.000852	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000355	0.000844	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TERT—malignant glioma	0.000348	0.000826	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000336	0.000799	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RTEL1—malignant glioma	0.000331	0.000788	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.00033	0.000784	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000325	0.000772	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000317	0.000753	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000316	0.000751	CbGpPWpGaD
Mebendazole—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000312	0.000741	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000307	0.000729	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—malignant glioma	0.000299	0.00071	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CXCL8—malignant glioma	0.000298	0.000708	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000296	0.000705	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000295	0.0007	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000294	0.0007	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000294	0.000698	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000293	0.000697	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000292	0.000694	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000291	0.000692	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000288	0.000684	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000287	0.000682	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000273	0.000649	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—malignant glioma	0.000267	0.000634	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000266	0.000632	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000265	0.00063	CbGpPWpGaD
Mebendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000261	0.000619	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—F2—malignant glioma	0.000255	0.000606	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000249	0.000592	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—COX8A—malignant glioma	0.000238	0.000566	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—malignant glioma	0.000238	0.000565	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000237	0.000563	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MDM2—malignant glioma	0.000231	0.000548	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—malignant glioma	0.000219	0.000521	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—MMP2—malignant glioma	0.000216	0.000514	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000214	0.000508	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000213	0.000506	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000212	0.000505	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000211	0.000501	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000206	0.000489	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000204	0.000485	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000203	0.000483	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ASMT—malignant glioma	0.000203	0.000482	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000202	0.00048	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000199	0.000473	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000198	0.000471	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—BCAN—malignant glioma	0.00019	0.000453	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—COX8A—malignant glioma	0.00019	0.000452	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000184	0.000436	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—malignant glioma	0.00018	0.000428	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CXCL8—malignant glioma	0.00018	0.000427	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000173	0.000411	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000164	0.000391	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000162	0.000385	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ASMT—malignant glioma	0.000162	0.000385	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000162	0.000385	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000161	0.000384	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—malignant glioma	0.000161	0.000383	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00016	0.00038	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000156	0.000371	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—IDH2—malignant glioma	0.000154	0.000365	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—BCAN—malignant glioma	0.000152	0.000362	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000149	0.000353	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000145	0.000344	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000145	0.000344	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2B6—malignant glioma	0.000144	0.000343	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000141	0.000336	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000136	0.000324	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—malignant glioma	0.000132	0.000315	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—IDH1—malignant glioma	0.000132	0.000314	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SPHK1—malignant glioma	0.000128	0.000304	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2C18—malignant glioma	0.000125	0.000298	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000123	0.000292	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—IDH2—malignant glioma	0.000123	0.000292	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000118	0.000281	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—COX8A—malignant glioma	0.000117	0.000279	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000115	0.000274	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000113	0.000269	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000111	0.000263	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000108	0.000256	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—IDH1—malignant glioma	0.000105	0.000251	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000105	0.000251	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000105	0.000249	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000104	0.000247	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SPHK1—malignant glioma	0.000102	0.000243	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTT1—malignant glioma	0.000101	0.000241	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2C18—malignant glioma	0.0001	0.000238	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ASMT—malignant glioma	9.97e-05	0.000237	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	9.61e-05	0.000228	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS1—malignant glioma	9.49e-05	0.000225	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.45e-05	0.000225	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—BCAN—malignant glioma	9.37e-05	0.000223	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	9.29e-05	0.000221	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—BCHE—malignant glioma	8.82e-05	0.00021	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC5A5—malignant glioma	8.71e-05	0.000207	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.24e-05	0.000196	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.16e-05	0.000194	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTT1—malignant glioma	8.09e-05	0.000192	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	7.85e-05	0.000187	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS1—malignant glioma	7.58e-05	0.00018	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—IDH2—malignant glioma	7.56e-05	0.00018	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.12e-05	0.000169	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.1e-05	0.000169	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—BCHE—malignant glioma	7.04e-05	0.000167	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—malignant glioma	7.02e-05	0.000167	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC5A5—malignant glioma	6.96e-05	0.000165	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CAT—malignant glioma	6.83e-05	0.000162	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—IDH1—malignant glioma	6.5e-05	0.000154	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOR1—malignant glioma	6.45e-05	0.000153	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.41e-05	0.000152	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SPHK1—malignant glioma	6.29e-05	0.000149	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.16e-05	0.000146	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—malignant glioma	5.6e-05	0.000133	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CAT—malignant glioma	5.45e-05	0.00013	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CAV1—malignant glioma	5.26e-05	0.000125	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOR1—malignant glioma	5.15e-05	0.000122	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.02e-05	0.000119	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTT1—malignant glioma	4.98e-05	0.000118	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—malignant glioma	4.79e-05	0.000114	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS1—malignant glioma	4.67e-05	0.000111	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARG—malignant glioma	4.62e-05	0.00011	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—BCHE—malignant glioma	4.34e-05	0.000103	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.29e-05	0.000102	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CD—malignant glioma	4.21e-05	0.0001	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CAV1—malignant glioma	4.2e-05	9.98e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—malignant glioma	3.82e-05	9.09e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARG—malignant glioma	3.69e-05	8.77e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CB—malignant glioma	3.67e-05	8.72e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—malignant glioma	3.64e-05	8.64e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—malignant glioma	3.45e-05	8.21e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CD—malignant glioma	3.36e-05	7.99e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CAT—malignant glioma	3.36e-05	7.99e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOR1—malignant glioma	3.17e-05	7.54e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTEN—malignant glioma	3.17e-05	7.54e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CB—malignant glioma	2.93e-05	6.97e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—malignant glioma	2.9e-05	6.9e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CAV1—malignant glioma	2.59e-05	6.15e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTEN—malignant glioma	2.53e-05	6.02e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.36e-05	5.6e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARG—malignant glioma	2.27e-05	5.41e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.24e-05	5.32e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.07e-05	4.92e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—malignant glioma	1.83e-05	4.34e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.81e-05	4.29e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—malignant glioma	1.79e-05	4.25e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CA—malignant glioma	1.79e-05	4.25e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTEN—malignant glioma	1.56e-05	3.71e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—malignant glioma	1.46e-05	3.47e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.1e-05	2.62e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—malignant glioma	8.99e-06	2.14e-05	CbGpPWpGaD
